Clonal hematologic disorders in Down syndrome. A review
- PMID: 7743232
- DOI: 10.1097/00043426-199502000-00003
Clonal hematologic disorders in Down syndrome. A review
Abstract
Purpose: Children with Down syndrome (DS) carry an elevated risk of developing clonal hematologic disorders. In this review, we summarize reported data describing the incidence of leukemia in children with DS and associated leukemic cell phenotypic and functional features.
Patients and methods: Major leukemic subtypes, acute lymphoblastic leukemia (ALL), acute nonlymphoblastic leukemia (ANLL), myelodysplastic syndromes (MDS), and transient abnormal myelopoiesis (TAM) are evaluated in the context of patient age and treatment responsiveness.
Results: It is apparent that although leukemia in children with DS is a relatively frequent event, prognosis with current conventional therapeutic strategies is excellent.
Conclusions: Treatment options for TAM, a monoclonal cellular proliferation in neonates, are discussed.
Similar articles
-
Acute leukemias in children with Down syndrome.Mol Genet Metab. 2012 Sep;107(1-2):25-30. doi: 10.1016/j.ymgme.2012.07.011. Epub 2012 Jul 20. Mol Genet Metab. 2012. PMID: 22867885 Review.
-
Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.Semin Fetal Neonatal Med. 2012 Aug;17(4):196-201. doi: 10.1016/j.siny.2012.02.010. Epub 2012 Mar 14. Semin Fetal Neonatal Med. 2012. PMID: 22421527 Review.
-
[Transient abnormal myelopoiesis followed by acute leukemia in children with Down syndrome].Rinsho Ketsueki. 1990 Dec;31(12):1939-44. Rinsho Ketsueki. 1990. PMID: 2150419 Japanese.
-
Cytogenetic and molecular study of 32 Down syndrome families: potential leukaemia predisposing role of the most proximal segment of chromosome 21q.Br J Haematol. 1998 Oct;103(1):213-6. doi: 10.1046/j.1365-2141.1998.00924.x. Br J Haematol. 1998. PMID: 9792310
-
Hematological disorders and leukemia in children with Down syndrome.Eur J Pediatr. 2012 Sep;171(9):1301-7. doi: 10.1007/s00431-011-1624-1. Epub 2011 Nov 24. Eur J Pediatr. 2012. PMID: 22113227 Review.
Cited by
-
Developmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation.J Clin Invest. 2013 Jul 1;123(8):3292-304. doi: 10.1172/JCI40609. Online ahead of print. J Clin Invest. 2013. PMID: 23863621 Free PMC article.
-
Lineage conversion from acute lymphoblastic leukemia to acute myeloid leukemia on rearrangement of the IgH gene in a patient with Down syndrome.Int J Hematol. 2002 Jul;76(1):69-73. doi: 10.1007/BF02982721. Int J Hematol. 2002. PMID: 12138899
-
Genetic predisposition in pediatric oncology.Med Pharm Rep. 2020 Oct;93(4):323-334. doi: 10.15386/mpr-1576. Epub 2020 Oct 25. Med Pharm Rep. 2020. PMID: 33225257 Free PMC article. Review.
-
Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome.Eur J Pediatr. 2004 Jul;163(7):374-7. doi: 10.1007/s00431-004-1452-7. Epub 2004 Apr 28. Eur J Pediatr. 2004. PMID: 15138809
-
Malignancies in Down syndrome.Indian J Pediatr. 1997 Nov-Dec;64(6):873-8. doi: 10.1007/BF02725515. Indian J Pediatr. 1997. PMID: 10771932
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous